Head & Neck/Thyroid Cancers
News
FDA: Cell phones still look safe
The available evidence does not suggest a causal link between cell phone use and cancer, according to the FDA.
From the Journals
Global project reveals cancer’s genomic playbook
The Pan-Cancer Analysis of Whole Genomes, an international collaboration, reveals the complexity of oncogenesis.
From the Journals
Lenvatinib/pembrolizumab has good activity in advanced RCC, other solid tumors
Two-thirds of patients with advanced renal cell carcinoma had a clinical response to the TKI/immune checkpoint inhibitor combination.
Latest News
Multimodal therapies almost double survival in anaplastic thyroid cancer
CHICAGO – One cancer center’s experience shows that a targeted, multidisciplinary approach makes a difference.
Latest News
Opioid-free regimen after neck dissection keeps patients comfortable
CHICAGO – A multimodal approach can also help reduce waste and the potential for addiction.
From the Journals
Immune-related toxicities, hospitalization common with checkpoint inhibitor therapy
The most common immune-related adverse events warranting hospital admission were pneumonitis and colitis.
News
FDA approves Keytruda for metastatic HNSCC
The approval was based on findings from the KEYNOTE-048 trial.
Conference Coverage
Ado-trastuzumab highly efficacious for rare HER2-amplified SGCs
CHICAGO – Ado-trastuzumab emtansine, previously known as T-DM1, is highly efficacious in patients with HER2-...
Conference Coverage
Pembro with or without chemo superior to EXTREME for advanced HNSCC
CHICAGO – Pembrolizumab with and without chemotherapy proved superior for overall survival vs. the EXTREME regimen...
From the Journals
Novel anti-PD-1 antibody can be given subcutaneously
“Subcutaneous administration of an anti-PD-1 antibody in patients with advanced solid tumors appears to be feasible,” the investigators wrote.
From the Journals
Study finds inconsistent links with aspirin, nonaspirin NSAIDs and reduced skin cancer risk
“We observed weak and inconsistent inverse associations between use of these medications and incidence of either BCC or SCC.”